# CT COMPARE: CT Coronary Angiography to Measure Plaque Reduction

> **NCT02740699** · PHASE4 · TERMINATED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 79 (actual)

## Conditions studied

- Cardiovascular Disease

## Interventions

- **DRUG:** Rosuvastatin
- **DRUG:** Atorvastatin
- **RADIATION:** Cardiac Computed Tomography (CT)
- **RADIATION:** Cardiac Magnetic Resonance Image (MRI)

## Key facts

- **NCT ID:** NCT02740699
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-04-11
- **Primary completion:** 2022-01-27
- **Final completion:** 2022-03-11
- **Target enrollment:** 79 (ACTUAL)
- **Why stopped:** Principal Investigator resigned and closed program
- **Last updated:** 2024-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02740699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02740699, "CT COMPARE: CT Coronary Angiography to Measure Plaque Reduction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02740699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*